drugset / Trial / NCT00637182

Gynecomastia Extension Study

NCT00637182

Phase 3 Completed AstraZeneca
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to look at the effect of anastrozole (ZD1033, Arimidex™) in reducing gynecomastia in pubertal boys treated with placebo in Trial 1033US/0006 (another anastrozole study).

Timeline

Start
2001-01
Primary completion
2002-06
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified

Indications